0001104659-17-048730.txt : 20170802 0001104659-17-048730.hdr.sgml : 20170802 20170802121304 ACCESSION NUMBER: 0001104659-17-048730 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170802 DATE AS OF CHANGE: 20170802 EFFECTIVENESS DATE: 20170802 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 17999008 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 06-30-2017 06-30-2017 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger 415-801-8100 /s/ Robin L. Praeger San Francisco CA 08-01-2017 0 8 127127265 false INFORMATION TABLE 2 a17-18764_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 9542795 101855 SH OTR 0 101855 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 6039940 1048601 SH OTR 0 1048601 0 Achaogen, Inc. Common Stock 004449104 27852244 1281152 SH OTR 0 1281152 0 Second Sight Medical Products, Inc. Common Stock 81362J100 5616219 4492975 SH OTR 0 4492975 0 Ocular Therapeutix, Inc. Common Stock 67576A100 20536610 2215384 SH OTR 0 2215384 0 OpGen, Inc. Common Stock 68373L109 1647466 2554211 SH OTR 0 2554211 0 Audentes Therapeutics, Inc. Common Stock 05070R104 34582764 1806832 SH OTR 0 1806832 0 ImmuneDesign Corp. Common Stock 45252L103 21309227 2208210 SH OTR 0 2208210 0